Cancer Fund

Cancer Fund is an early-stage impact venture capital firm focused on investing in innovative startups developing new cancer therapies, diagnostics, and prevention methods. The firm primarily operates in Hong Kong and China, targeting companies that can transform promising cancer innovations into breakthrough treatments and care. While specific investment sizes are not disclosed, Cancer Fund supports early-stage ventures with the potential to make significant impacts in the oncology sector.

Notable portfolio companies include AOA Dx, which has raised $17 million to advance its cancer diagnostic technologies. The firm's investment philosophy centers on creating real impact by turning hope into reality through strategic investments in cancer innovation. Cancer Fund also offers unique value-add services, leveraging its extensive network and expertise in cancer research and patient support to help portfolio companies succeed. Key decision-makers and partners are not specified, but the firm’s commitment to both financial returns and social impact is evident in its dual role as a venture capital fund and a non-profit organization.